Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review. (Q38205937)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

title

Barriers to care and treatment for patients with chronic viral hepatitis in Europe: a systematic review (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

George Papatheodoridis

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

4

Heiner Wedemeyer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

author name string

Svenja Hardtke

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

publication date

16 May 2014

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

volume

34

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

14 March 2020

page(s)

1452-1463

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24750532%20AND%20SRC:MED&resulttype=core&format=json

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

14 March 2020

cites work

1 reference

The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*.

21 January 2018

1 reference

EASL clinical practice guidelines: Management of chronic hepatitis B virus infection

21 January 2018

1 reference

Therapeutic strategies in the management of patients with chronic hepatitis B virus infection.

21 January 2018

1 reference

A sustained virologic response reduces risk of all-cause mortality in patients with hepatitis C.

21 January 2018

1 reference

Association between sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis.

21 January 2018

1 reference

EASL Clinical Practice Guidelines: management of hepatitis C virus infection

21 January 2018

1 reference

Current progress in the treatment of chronic hepatitis C.

21 January 2018

1 reference

Hepatitis C in 2012: On the fast track towards IFN-free therapy for hepatitis C?

21 January 2018

1 reference

Modelling the past, current and future HCV burden in France: detailed analysis and perspectives

21 January 2018

1 reference

Future trends of HCV-related cirrhosis and hepatocellular carcinoma under the currently available treatments

21 January 2018

1 reference

Is chronic hepatitis B being undertreated in the United States?

21 January 2018

1 reference

Barriers to hepatitis C treatment

21 January 2018

1 reference

Public health issues of hepatitis C virus infection.

21 January 2018

1 reference

Eligibility and feasibility of the treatment of chronic hepatitis C in a Cohort of Italian HIV-positive patients at a single HIV reference center.

21 January 2018

1 reference

Factors associated with access to antiviral treatment in a multicentre cross-sectional study of patients with chronic hepatitis B in Italy.

21 January 2018

1 reference

Treatment of hepatitis C infection in injection drug users

21 January 2018

1 reference

Treatment of hepatitis C virus in human immunodeficiency virus infected patients in "real life": modifications in two large surveys between 2004 and 2006.

21 January 2018

1 reference

Management of hepatitis C among drug users attending general practice in Ireland: baseline data from the Dublin area hepatitis C in general practice initiative.

21 January 2018

1 reference

The impact of the prevention programme of hepatitis C over more than a decade: the French experience

21 January 2018

1 reference

Hepatitis C infection: eligibility for antiviral therapies

21 January 2018

1 reference

Cross-sectional epidemiology of hepatitis C virus detection and treatment in HIV-infected patients

21 January 2018

1 reference

Is the management of hepatitis C patients appropriate? A population-based study.

21 January 2018

1 reference

Hepatitis C testing and treatment among active drug users in Amsterdam: results from the DUTCH-C project

21 January 2018

1 reference

Place of residence and distance to medical care influence the diagnosis of hepatitis C: a population-based study

21 January 2018

1 reference

Chronic Hepatitis C virus infection in Swiss primary care practices: low case loads-high barriers to treatment?

21 January 2018

1 reference

Frequency and predictors of no treatment in anti-hepatitis C virus-positive patients at tertiary liver centers in Greece.

21 January 2018

1 reference

Variation in hepatitis C services may lead to inequity of heath-care provision: a survey of the organisation and delivery of services in the United Kingdom

21 January 2018

1 reference

Hepatitis B virus-human immunodeficiency virus co-infection in France: a cross-sectional multicentre study

21 January 2018

1 reference

Evolving clinical landscape of chronic hepatitis B: A multicenter Italian study

21 January 2018

1 reference

Hepatitis C virus infection among drug addicts in Italy.

21 January 2018

1 reference

Current practice of chronic hepatitis B treatment in Southern Italy

21 January 2018

1 reference

Current practice of hepatitis C treatment in Southern Italy

21 January 2018

1 reference

The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.

21 January 2018

1 reference

Factors to improve the management of hepatitis C in drug users: an observational study in an addiction centre

21 January 2018

1 reference

Institute of Medicine recommendations for the prevention and control of hepatitis B and C.

21 January 2018

1 reference

Patterns and predictors of treatment initiation and completion in patients with chronic hepatitis C virus infection

21 January 2018

1 reference

Gaps in the achievement of effectiveness of HCV treatment in national VA practice

21 January 2018

1 reference

Current treatment indications and strategies in chronic hepatitis B virus infection.

21 January 2018

1 reference

Predictors associated with treatment initiation and switch in a real-world chronic hepatitis B population from five European countries

21 January 2018

1 reference

The burden and recent epidemiological changes of the main chronic liver diseases in a Greek referral tertiary centre.

21 January 2018

1 reference

Changing epidemiology of hepatitis B and migration--a comparison of six Northern and North-Western European countries

21 January 2018

1 reference

Absolute and relative contraindications to pegylated-interferon or ribavirin in the US general patient population with chronic hepatitis C: results from a US database of over 45 000 HCV-infected, evaluated patients

21 January 2018

1 reference

Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews

21 January 2018

1 reference

Combination interventions to prevent HCV transmission among people who inject drugs: modeling the impact of antiviral treatment, needle and syringe programs, and opiate substitution therapy

21 January 2018

1 reference

Hepatitis C virus treatment for prevention among people who inject drugs: Modeling treatment scale-up in the age of direct-acting antivirals

21 January 2018

1 reference

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

21 January 2018

1 reference